Clinical Trials
3 trialsNCT03731026 2018-11-06
The LightPath® and 68Ga-RM2 in Breast Cancer Study
Lightpoint Medical Limited
Phase 3 Unknown
NCT02483884 2017-03-22
PET/CT Imaging Study of the Safety and Diagnostic Performance of [68Ga]RM2 in Patients With Primary Prostate Cancer
Lantheus Biosciences Ltd.
Phase 1/2 Terminated
NCT01205321 2013-01-21
PET/CT Imaging for Radiation Dosimetry, Plasma Pharmacokinetics, Biodistribution, Safety and Tolerability and Diagnostic Performance of BAY86-7548 in Patients With Prostate Cancer and Healthy Volunteers
Lantheus Biosciences Ltd.
Phase 1 Completed